Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease A Kulshreshtha, P Piplani Neurological Sciences 37, 1403-1435, 2016 | 96 | 2016 |
The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases CC Danta, P Piplani Expert opinion on drug discovery 9 (10), 1205-1222, 2014 | 56 | 2014 |
Towards better brain management: nootropics R Malik, A Sangwan, R Saihgal, D Paul Jindal, P Piplani Current medicinal chemistry 14 (2), 123-131, 2007 | 56 | 2007 |
Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors PK Deb, A Sharma, P Piplani, RR Akkinepally Molecular Diversity 16, 803-823, 2012 | 47 | 2012 |
Exploring the chemistry and therapeutic potential of triazoles: a comprehensive literature review A Jain, P Piplani Mini Reviews in Medicinal Chemistry 19 (16), 1298-1368, 2019 | 41 | 2019 |
Microwave‐activated Synthesis of Pyrroles: A Short Review A Sharma, P Piplani Journal of Heterocyclic Chemistry 54 (1), 27-34, 2017 | 39 | 2017 |
Ameliorative effects of amide derivatives of 1, 3, 4-thiadiazoles on scopolamine induced cognitive dysfunction A Kulshreshtha, P Piplani European journal of medicinal chemistry 122, 557-573, 2016 | 34 | 2016 |
Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies S Singla, P Piplani Bioorganic & Medicinal Chemistry 24 (19), 4587-4599, 2016 | 34 | 2016 |
Design and synthesis of newer potential 4-(N-acetylamino) phenol derived piperazine derivatives as potential cognition enhancers P Piplani, CC Danta Bioorganic Chemistry 60, 64-73, 2015 | 24 | 2015 |
Rho-kinase (ROCK) inhibitors-a neuroprotective therapeutic paradigm with a focus on ocular utility V Abbhi, P Piplani Current Medicinal Chemistry 27 (14), 2222-2256, 2020 | 21 | 2020 |
Synthesis and neuromuscular blocking activity of 16β-piperidinosteroidal derivatives DP Jindal, P Piplani, H Fajrak, C Prior, IG Marshall European journal of medicinal chemistry 36 (2), 195-202, 2001 | 20 | 2001 |
Synthesis and in vitro Antineoplastic Evaluation of Certain 16‐(4‐Substituted Benzylidene) Derivatives of Androst‐5‐ene S Dubey, P Piplani, DP Jindal Chemistry & biodiversity 1 (10), 1529-1536, 2004 | 19 | 2004 |
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma V Abbhi, L Saini, S Mishra, G Sethi, AP Kumar, P Piplani Bioorganic & Medicinal Chemistry 25 (21), 6071-6085, 2017 | 16 | 2017 |
Design, synthesis and pharmacological evaluation of some novel indanone derivatives as acetylcholinesterase inhibitors for the management of cognitive dysfunction P Piplani, A Jain, D Devi, A Sharma, P Silakari Bioorganic & Medicinal Chemistry 26 (1), 215-224, 2018 | 14 | 2018 |
Synthesis and neuromuscular blocking activity of 16β-N-methylpiperazino steroidal derivatives DP Jindal, P Piplani, H Fajrak, C Prior, IG Marshall European journal of medicinal chemistry 37 (11), 901-908, 2002 | 14 | 2002 |
Design, synthesis and biological evaluation of triazole-oxadiazole conjugates for the management of cognitive dysfunction A Jain, P Piplani Bioorganic Chemistry 103, 104151, 2020 | 13 | 2020 |
p-Benzoquinone as a privileged scaffold of pharmacological significance: A Review P Silakari, P Piplani Mini reviews in medicinal chemistry 20 (16), 1586-1609, 2020 | 13 | 2020 |
Synthesis and evaluation of some 16-benzylidene substituted 3, 17-dioximino androstene derivatives as anticancer agents S Dubey, P Piplani, DP Jindal Letters in Drug Design & Discovery 2 (7), 537-545, 2005 | 13 | 2005 |
Synthesis and antineoplastic activity of some 16-benzylidene substituted steroidal oximes S Dubey, DP Jindal, P Piplani CSIR, 2005 | 13 | 2005 |
Design and synthesis of some acridine‐piperazine hybrids for the improvement of cognitive dysfunction A Sharma, P Piplani Chemical Biology & Drug Design 90 (5), 926-935, 2017 | 12 | 2017 |